Page last updated: 2024-10-23

azathioprine and Malignant Fibrohistiocytic Tumors

azathioprine has been researched along with Malignant Fibrohistiocytic Tumors in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research Excerpts

ExcerptRelevanceReference
"Pathology revealed T1aNxM0 pleomorphic malignant fibrous histiocytoma or undifferentiated pleomorphic sarcoma."1.38Pleomorphic malignant histiocytoma: a rare skin cancer in a patient on azathioprine for ulcerative colitis. ( Daw, HA; Sood, R, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sood, R1
Daw, HA1

Other Studies

1 other study available for azathioprine and Malignant Fibrohistiocytic Tumors

ArticleYear
Pleomorphic malignant histiocytoma: a rare skin cancer in a patient on azathioprine for ulcerative colitis.
    BMJ case reports, 2012, Jul-03, Volume: 2012

    Topics: Aged; Azathioprine; Colitis, Ulcerative; Female; Histiocytoma, Malignant Fibrous; Humans; Immunosupp

2012